The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach

Mise à jour : Il y a 4 ans
Référence : NCT02363517

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study will investigate the feasibility of treating people who inject drugs (PWID) with hepatitis C virus (HCV) in community-based settings with a 12-week course of oral therapy combination of sofosbuvir plus ledipasvir. It will also measure the effectiveness of using a social network-based approach to reduce HCV incidence among PWID.


Critère d'inclusion

  • Hepatitis C,Drug Abuse, Intravenous

Liens